Delivery Order SPE2DB24D2205-SPE2DB24FDZYA
Award Date
9/16/24
Potential Completion Date
9/17/24
Potential Value
$47K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The firm-fixed-price delivery order, valued at $4,849.99, has an ultimate completion date of August 23, 2024. Amerisourcebergen, through its Corporate Office division, provides a wide range of essential pharmaceutical products and medical supplies to support various government agencies and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a total ceiling value of $2,051.22. The contract is a Firm Fixed Price Delivery Order with a performance period through March 10, 2025. The contract is not associated with any set-aside requirements. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $100,678.50 firm fixed-price delivery order is for the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with a period of performance through April 23, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines. The $51,403.78 firm-fixed price delivery order has a completion date of September 12, 2024 and does not have a set-aside designation. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,482.00 firm fixed-price delivery order is for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,528.75 firm fixed price delivery order supports the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has a completion date of September 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product to the Defense Logistics Agency (DLA). The contract, awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office division, has a ceiling value of $7,431.64 and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,224.50 firm-fixed-price delivery order is for the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with an ultimate completion date of May 30, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,561.85 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2023, with a ceiling value of $29,286.50 and a completion date of February 27, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...